Skip to content
ClinCalc Pro
Menu
Direct vasodilator / hair-growth stimulator Pregnancy: Limited data in pregnant women; animal studies have shown reproductive toxicity. Not recommended during pregnancy or in women of childbearing potential not using contraception. Neonatal hirsutism has been reported after exposure in pregnancy. Excreted in human milk — a risk to the suckling child cannot be excluded.

Minoxidil

Brand names: Loniten, Regaine (topical)

Minoxidil is a potent oral arterial vasodilator used for severe, treatment-resistant hypertension, usually in combination with other antihypertensives.

Auto-extracted from the source labelling — not yet independently clinician-verified. These values were distilled from the UK SPC (or the US label where noted) but have not had a clinician sign-off. Confirm against the current SmPC before prescribing.

Adult dose

Dose: Patients over 12 years and adults: recommended starting dose 5 mg per day; if required this may be increased up to 20 mg, and then to 40 mg daily (as a single dose or in two divided doses).
Route: Oral
Frequency: Once daily, or in two divided doses (divide into two daily doses if the decrease in diastolic blood pressure exceeds 30 mmHg)
Max: Maximum 100 mg per day (once 50 mg/day is reached, the dose may be increased by 25 mg per day up to this maximum)
Source: Minoxidil 10 mg Tablets SPC §4.2 (oral minoxidil for hypertension). Dose increases should be made in increments of 5 mg to 10 mg per day at intervals of three or more days. Rapid reduction of blood pressure: under hospital monitoring conditions this can be achieved using continuous blood pressure monitoring and incremental doses of 5 mg every six hours. Elderly: no extensive clinical studies over age 65; elderly patients may be sensitive to the blood-pressure-lowering effect and orthostatic hypotension may occur — an initial starting dose of 2.5 mg per day is suggested in patients over 65. Mandatory co-therapy per SPC §4.2: minoxidil causes sodium retention, so in all patients not on dialysis it must be given with a diuretic in sufficient dosage to maintain salt and water balance (examples of daily starting dosages quoted: hydrochlorothiazide 100 mg or another thiazide at equi-effective dosage, chlortalidone 100 mg, or furosemide 80 mg; switch to furosemide if water retention causes weight gain over 3 pounds on a thiazide/chlortalidone). Patients also require a sympathetic nervous system suppressant to limit minoxidil-induced rise in heart rate — the preferred agent is a beta-blocker equivalent to an adult propranolol dosage of 80-160 mg/day (higher doses may be needed if heart rate rises by more than 20 bpm in pre-treated patients or more than 10 bpm on simultaneous introduction); where beta-blockers are contraindicated, alternatives such as methyldopa may be used and should be started 24 hours before minoxidil. Where possible, antihypertensive therapy other than a beta-adrenergic blocking agent and a diuretic should be discontinued before starting minoxidil, tapering gradually over the first week for drugs that should not be stopped abruptly. NOTE: the US openFDA record retrieved for 'minoxidil' was a topical over-the-counter hair-regrowth product (different indication and route) and was NOT used for this oral antihypertensive dose.

Paediatric dose

Dose: 0.2 mg/kg
Route: Oral
Frequency: Starting dose given as a single or divided daily dose
Max: 50 mg/day
SPC §4.2, patients younger than 12 years: use is restricted to children with severe hypertension associated with target organ damage where other treatment has failed. Data are very limited (a few case reports and small studies), especially in infants, and the recommendations are only a rough guide. Starting dose 0.2 mg/kg as a single or divided dose; careful titration in steps of 0.1 to 0.2 mg/kg/day at intervals of at least 3 days is essential; effective dose range 0.25 to 1.0 mg/kg/day; maximum dose 50 mg/day. Treatment of children with minoxidil should only be initiated under the close supervision of a specialist in hospital. Diuretic dosage in children should be proportionally less in relation to weight. Verify against a children's formulary before prescribing.

Dose adjustments

Renal

Dosage requirements may be lower in dialysis patients. Minoxidil is removed from the blood by dialysis but its pharmacological action, once established, is not reversed — haemodialysis patients should take minoxidil either after dialysis or at least two hours before it. Patients with renal failure or on haemodialysis may require smaller doses (SPC §4.2/§4.4).

Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.

Paediatric weight-based calculator

SPC §4.2, patients younger than 12 years: use is restricted to children with severe hypertension associated with target organ damage where other treatment has failed. Data are very limited (a few case reports and small studies), especially in infants, and the recommendations are only a rough guide. Starting dose 0.2 mg/kg as a single or divided dose; careful titration in steps of 0.1 to 0.2 mg/kg/day at intervals of at least 3 days is essential; effective dose range 0.25 to 1.0 mg/kg/day; maximum dose 50 mg/day. Treatment of children with minoxidil should only be initiated under the close supervision of a specialist in hospital. Diuretic dosage in children should be proportionally less in relation to weight. Verify against a children's formulary before prescribing.

Verify in a children's formulary

Contraindications

  • Hypersensitivity to the active substance or to any of the excipients
  • Phaeochromocytoma (minoxidil may stimulate catecholamine secretion from the tumour through its antihypertensive action)

Side effects

  • Hypertrichosis and hair colour changes (hypertrichosis occurs in most patients)
  • Fluid retention, oedema; peripheral oedema with or independent of weight gain
  • Tachycardia; pericarditis
  • Pericardial effusion, cardiac tamponade; pleural effusion
  • Abnormal ECG (T-wave changes); leucopoenia, thrombocytopenia

Clinical monograph

How it works

Its active sulphate metabolite opens ATP-sensitive potassium channels in arteriolar smooth muscle, causing relaxation and a fall in peripheral vascular resistance and blood pressure.

Prescribing in practice

  • It causes marked fluid retention and reflex tachycardia, so it must almost always be co-prescribed with a diuretic and a beta-blocker (or other rate-controlling agent) to prevent oedema and angina.
  • Pericardial effusion, occasionally progressing to tamponade, has been reported and warrants vigilance.
  • Hypertrichosis is common and frequently leads to discontinuation, particularly in women; consult the SPC before prescribing.

Monitoring

Monitor blood pressure, heart rate, body weight and fluid status, watching for signs of pericardial effusion.

Counselling the patient

  • Warn the patient about increased growth of body and facial hair, which is reversible on stopping.
  • Advise reporting rapid weight gain, ankle swelling or breathlessness, and not to stop the medicine abruptly.

Evidence & guidelines

Oral minoxidil is reserved for resistant hypertension under specialist supervision; refer to current prescribing references.

Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.